Ray Dalio Pfizer Inc Transaction History

Bridgewater Associates, LP

$17.3 Billion
Q3 2024

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Pfizer Inc stock. As of the latest transaction made, Bridgewater Associates, LP holds 11,847 shares of PFE stock, worth $295,464. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,847

Previous 35,427 66.56%

Holding current value

$295,464

Previous $991,000 65.49%

% of portfolio

0.0%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$27.7 - $31.39 $653,166 - $740,176	-23,580 Reduced 66.56%	11,847 $342,000
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $1.01 Million - $1.19 Million	-40,179 Reduced 53.14%	35,427 $991,000
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $31.2 Million - $35.8 Million	-1,205,825 Reduced 94.1%	75,606 $2.1 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $8.84 Million - $11.5 Million	-338,136 Reduced 20.88%	1,281,431 $36.9 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $5.33 Million - $6.23 Million	-166,015 Reduced 9.3%	1,619,567 $53.7 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $3.99 Million - $4.62 Million	110,564 Added 6.6%	1,785,582 $65.5 Million
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $41.8 Million - $54.4 Million	-1,061,570 Reduced 38.79%	1,675,018 $68.3 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $4.25 Million - $5.55 Million	-101,884 Reduced 3.59%	2,736,588 $140 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $7.84 Million - $9.57 Million	-179,203 Reduced 5.94%	2,838,472 $124 Million
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $13.8 Million - $16.4 Million	-296,380 Reduced 8.94%	3,017,675 $158 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $118 Million - $146 Million	2,581,384 Added 352.33%	3,314,055 $172 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $23.4 Million - $34.8 Million	567,368 Added 343.23%	732,671 $43.3 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $156,136 - $200,570	3,978 Added 2.47%	165,303 $7.11 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $5.52 Million - $6.26 Million	153,839 Added 2055.02%	161,325 $6.32 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $250,706 - $282,746	7,486 New	7,486 $271,000
Q2 2020 Aug 12, 2020	SELL	$30.12 - $36.54 $2.53 Million - $3.07 Million	-84,142 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $2.27 Million - $3.25 Million	84,142 New	84,142 $2.75 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $11.5 Million - $13.1 Million	-298,598 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $3.02 Million - $3.67 Million	-87,708 Reduced 22.7%	298,598 $13.2 Million
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $6.33 Million - $6.75 Million	191,984 Added 98.8%	386,306 $0
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $6.2 Million - $7.19 Million	194,322 New	194,322 $6.9 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $140B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account